Что делать?

Закрыть метаданные

ЦМВ-колит у пациентов с воспалительными заболеваниями кишечника: диагностика и лечение.

Авторы:

Соловей Н.В.

УЗ «Городская клиническая инфекционная больница», Минск, Республика Беларусь

SPIN РИНЦ: 4425-6034
Scopus AuthorID: 57195676839

Карпов И.А.

УО «Белорусский государственный медицинский университет», Минск, Республика Беларусь

SPIN РИНЦ: 6594-8929
Scopus AuthorID: 15832060600

Список литературы:

Zuhair M, Smit GSA, Wallis G, Jabbar F, Smith C, Devleesschauwer B, Griffiths P. Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis. Rev Med Virol. 2019 May;29(3): e2034. https://doi.org/10.1002/rmv.2034
Fernández S, Castro P & Azoulay E. What intensivists need to know about cytomegalovirus infection in immunocompromised ICU patients. Intensive Care Med. 2025 Jan;51(1):39-61. https://doi.org/10.1007/s00134-024-07737-5
Yokoyama Y, Yamakawa T, Hirano T, et al. Current Diagnostic and Therapeutic Approaches to Cytomegalovirus Infections in Ulcerative Colitis Patients Based on Clinical and Basic Research Data. Int J Mol Sci. 2020 Mar 31;21(7):2438. https://doi.org/10.3390/ijms21072438
do Carmo AM, Santos FM, Ortiz-Agostinho CL, et al. Cytomegalovirus infection in inflammatory bowel disease is not associated with worsening of intestinal inflammatory activity. PLoS One. 2014 Nov 11;9(11): e111574. https://doi.org/10.1371/journal.pone.0111574
Bontà J, Zeitz J, Frei P, et al. Cytomegalovirus disease in inflammatory bowel disease: epidemiology and disease characteristics in a large single-centre experience. Eur J Gastroenterol Hepatol. 2016 Nov;28(11):1329-1334. https://doi.org/10.1097/MEG.0000000000000716
Lee HS, Park SH, Kim SH, et al. Risk Factors and Clinical Outcomes Associated with Cytomegalovirus Colitis in Patients with Acute Severe Ulcerative Colitis. Inflamm Bowel Dis. 2016 Apr;22(4):912-918. https://doi.org/10.1097/MIB.0000000000000675
Gauss A, Rosenstiel S, Schnitzler P, et al. Intestinal cytomegalovirus infection in patients hospitalized for exacerbation of inflammatory bowel disease: a 10-year tertiary referral center experience. Eur J Gastroenterol Hepatol. 2015 Jun;27(6):712-720. https://doi.org/10.1097/MEG.0000000000000361
Levin A, Yaari S, Stoff R, Caplan O, Wolf DG, Israeli E. Diagnosis of Cytomegalovirus Infection during Exacerbation of Ulcerative Colitis. Digestion. 2017;96(3):142-148. https://doi.org/10.1159/000479865
Maher MM, Nassar MI. Acute cytomegalovirus infection is a risk factor in refractory and complicated inflammatory bowel disease. Dig Dis Sci. 2009 Nov;54(11):2456-2462. https://doi.org/10.1007/s10620-008-0639-6
Criscuoli V, Casà A, Orlando A, et al. Severe acute colitis associated with CMV: a prevalence study. Dig Liver Dis. 2004 Dec;36(12):818-820. https://doi.org/10.1016/j.dld.2004.05.013
Cottone M, Pietrosi G, Martorana G, et al. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn’s colitis. Am J Gastroenterol. 2001 Mar;96(3):773-775. https://www.sci-hub.ru/10.1111/j.1572-0241.2001.03620.x
Cohen S, Martinez-Vinson C, Aloi M, et al. Cytomegalovirus Infection in Pediatric Severe Ulcerative Colitis-A Multicenter Study from the Pediatric Inflammatory Bowel Disease Porto Group of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. Pediatr Infect Dis J. 2018 Mar;37(3):197-201. https://doi.org/10.1097/INF.0000000000001724
Kim YS, Kim YH, Kim JS, et al. Long-term outcomes of cytomegalovirus reactivation in patients with moderate to severe ulcerative colitis: a multicenter study. Gut Liver. 2014 Nov;8(6):643-647. https://doi.org/10.5009/gnl13427
Schenk W, Klugmann T, Borkenhagen A, et al. The detection of the cytomegalovirus DNA in the colonic mucosa of patients with ulcerative colitis is associated with increased long-term risk of proctocolectomy: results from an outpatient IBD clinic. Int J Colorectal Dis. 2019 Mar;34(3):393-400. https://doi.org/10.1007/s00384-018-3210-8
Criscuoli V, Rizzuto MR, Gallo E, Orlando A, Cottone M. Toxic megacolon and human Cytomegalovirus in a series of severe ulcerative colitis patients. J Clin Virol. 2015 May;66:103-106. https://doi.org/10.1016/j.jcv.2015.03.009
Matsumoto S, Yoshida Y. What are the factors that affect hospitalization and surgery for aggravation of ulcerative colitis? Eur J Gastroenterol Hepatol. 2014 Mar;26(3):282-287. https://doi.org/10.1097/MEG.0000000000000028
Zhang WX, Ma CY, Zhang JG, et al. Effects of cytomegalovirus infection on the prognosis of inflammatory bowel disease patients. Exp Ther Med. 2016 Nov;12(5):3287-3293. https://doi.org/10.3892/etm.2016.3763
McCurdy JD, Jones A, Enders FT, et al. A model for identifying cytomegalovirus in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2015 Jan;13(1):131-137; quiz e7. https://doi.org/10.1016/j.cgh.2014.05.026
Henmi Y, Kakimoto K, Inoue T, et al. Cytomegalovirus infection in ulcerative colitis assessed by quantitative polymerase chain reaction: risk factors and effects of immunosuppressants. J Clin Biochem Nutr. 2018 Nov;63(3):246-251. https://doi.org/10.3164/jcbn.18-14
Tun GSZ, Raza M, Hale MF, Lobo AJ. Polymerase chain reaction for detection of mucosal cytomegalovirus infection in patients with acute ulcerative colitis. Ann Gastroenterol. 2019 Jan-Feb;32(1):81-87. https://doi.org/10.20524/aog.2018.0318
Nowacki TM, Bettenworth D, Meister T, et al. Novel score predicts risk for cytomegalovirus infection in ulcerative colitis. J Clin Virol. 2018 Aug;105:103-108. https://doi.org/10.1016/j.jcv.2018.06.002
Mavropoulou E, Ternes K, Mechie NC, et al. Cytomegalovirus colitis in inflammatory bowel disease and after haematopoietic stem cell transplantation: diagnostic accuracy, predictors, risk factors and disease outcome. BMJ Open Gastroenterol. 2019 Feb 27;6(1): e000258. https://doi.org/10.1136/bmjgast-2018-000258
Melotti L, Rinaldi M, Salice M, et al. Is CMV DNAemia an early marker of CMV colitis in patients with active ulcerative colitis? Microbiol Spectr. 2024 Nov 5;12(11):e0115924. https://doi.org/10.1128/spectrum.01159-24
Dalal RS, Mitri J, Goodrick H, Allegretti JR. Risk of Gastrointestinal Infections After Initiating Vedolizumab and Anti-TNFα Agents for Ulcerative Colitis. J Clin Gastroenterol. 2023 Aug 1;57(7):714-720. https://doi.org/10.1097/MCG.0000000000001733
Shieh AC, Guler E, Tirumani SH, Dumot J, Ramaiya NH. Clinical, imaging, endoscopic findings, and management of patients with CMV colitis: a single-institute experience. Emerg Radiol. 2020 Jun;27(3):277-284. https://doi.org/10.1007/s10140-020-01750-z
Le PH, Lin WR, Kuo CJ, et al. Clinical characteristics of cytomegalovirus colitis: a 15-year experience from a tertiary reference center. Ther Clin Risk Manag. 2017 Dec 15;13:1585-1593. https://doi.org/10.2147/TCRM.S151180
Esen S, Saglik I, Dolar E, et al. Diagnostic Utility of Cytomegalovirus (CMV) DNA Quantitation in Ulcerative Colitis. Viruses. 2024 Apr 26;16(5):691. https://doi.org/10.3390/v16050691
McCurdy JD, Enders FT, Jones A, et al. Detection of Cytomegalovirus in Patients with Inflammatory Bowel Disease: Where to Biopsy and How Many Biopsies? Inflamm Bowel Dis. 2015 Dec;21(12):2833-2838. https://doi.org/10.1097/MIB.0000000000000556
Roblin X, Pillet S, Oussalah A, et al. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis. Am J Gastroenterol. 2011 Nov;106(11):2001-2008. https://doi.org/10.1038/ajg.2011.202
Zidar N, Ferkolj I, Tepeš K, et al. Diagnosing cytomegalovirus in patients with inflammatory bowel disease – by immunohistochemistry or polymerase chain reaction? Virchows Arch. 2015 May;466(5):533-539. https://doi.org/10.1007/s00428-015-1741-8
Nguyen M, Bradford K, Zhang X, Shih DQ. Cytomegalovirus Reactivation in Ulcerative Colitis Patients. Ulcers. 2011 Jan 1;2011:282507. https://doi.org/10.1155/2011/282507
Herfarth HH, Long MD, Rubinas TC, Sandridge M, Miller MB. Evaluation of a non-invasive method to detect cytomegalovirus (CMV)-DNA in stool samples of patients with inflammatory bowel disease (IBD): a pilot study. Dig Dis Sci. 2010 Apr;55(4):1053-1058. https://doi.org/10.1007/s10620-010-1146-0
Ganzenmueller T, Kluba J, Becker JU, Bachmann O, Heim A. Detection of cytomegalovirus (CMV) by real-time PCR in fecal samples for the non-invasive diagnosis of CMV intestinal disease. J Clin Virol. 2014 Dec;61(4):517-522. https://doi.org/10.1016/j.jcv.2014.10.009
Hsieh CR, Wu RC, Kuo CJ, et al. Adequate antiviral treatment lowers overall complications of cytomegalovirus colitis among inpatients with inflammatory bowel diseases. BMC Infect Dis. 2024 Apr 26;24(1):443. https://doi.org/10.1186/s12879-024-09317-w
Panda K, Parashar D, Viswanathan R. An Update on Current Antiviral Strategies to Combat Human Cytomegalovirus Infection. Viruses. 2023 Jun 12;15(6):1358. https://doi.org/10.3390/v15061358
Kucharzik T, Ellul P, Greuter T, et al. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. J Crohns Colitis. 2021 Jun 22;15(6):879-913. https://doi.org/10.1093/ecco-jcc/jjab052
Gilmore RB, Taylor KM, Morrissey CO, Gardiner BJ. Cytomegalovirus in inflammatory bowel disease: a clinical approach. Intern Med J. 2022 Mar;52(3):365-368. https://doi.org/10.1111/imj.15085
Singh G, Rentsch C, Beattie W, Christensen B, Macrae F, Segal JP. Long-Term Follow Up of Patients Treated for Inflammatory Bowel Disease and Cytomegalovirus Colitis. Diagnostics (Basel). 2024 Sep 13;14(18):2030. https://doi.org/10.3390/diagnostics14182030

Закрыть метаданные